Радіонуклідні методи в діагностиці адреналових інсиденталом

Д. О. Джужа

doi:10.24026/1818-1384.2(50).2015.74994

Автор(и)

Д. О. Джужа Національний інститут раку, Київ, Україна

DOI:

https://doi.org/10.24026/1818-1384.2(50).2015.74994

Ключові слова:

адреналові інсиденталоми, позитронна емісійна томографія, 18Р-фтордезоксиглюкоза

Анотація

В огляді висвітлено основні питання застосування радіонуклідних методів діагностики в комплексному обстеженні хворих з випадково виявленими об’ємними утвореннями надниркових залоз і визначенні тактики подальшого лікування. Представлені показники діагностичної ефектив ності різних радіонуклідних методик із застосу ванням РФП як для однофотонної сцинтиграфії, так і для ПЕТ-технологій при різних клінічних ситуаціях у хворих з адреналовими інсиденталомами.

Біографія автора

Д. О. Джужа, Національний інститут раку, Київ

D.A. Dzhuzha

Посилання

Adrenal lesions: characterization with fused PET/CT image in patients with proved of suspected malignancy – initial experience / M. A. Blake, MA. James, J.M. Slattery [et al.] // Radiology. – 2006. – Vol. 238. – P. 970-977. http://dx.doi.org/10.1148/radiol.2383042164

Adrenal incidentaloma: a diagnostic challenge / P. Anagnostis, A. Karagiannis, K. Tziomalos [et al.] // Hormones. – 2009. – Vol. 8. – P. 163-184. http://dx.doi.org/10.14310/horm.2002.1233

Adrenal incidentaloma imaging – the first steps in therapeutic management / L. Papierska, A. Cichocki, A.J. Sankowski, J. Cwikla // Pol. J. Radiopl. – 2013. – Vol. 78, N 4. – P. 47-55. http://dx.doi.org/10.12659/pjr.889541

Adrenal masses: characterization with combined unenhanced and delayed enhanced CT / E.M. Caoili, M. Korobkin, I.R. Francis [et al] // Radiology. – 2002. – Vol. 222. – P. 629-633. http://dx.doi.org/10.1148/radiol.2223010766

Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions / M. Okada, T. Shimono, Y. Komeya [et al.] // Ann. Nucl. Med. – 2009. – Vol. 23. – P. 349-354. http://dx.doi.org/10.1007/s12149-009-0246-4

Adrenal tissue characterization using MR imaging / G.M. Glazer, E.J. Woolsey, J. Borrello [et al.] // Radiology. – 1986. – Vol. 158. – P. 73-79. http://dx.doi.org/10.1148/radiology.158.1.3940402

Adrenal-to-liver SUV ratio is the best parameter for differentiation of adrenal metastases from adenomas using (18)F-FDG PET/CT / H. Watanabe, M. Kanematsu, S. Goshima [et al.] // Ann. Nucl. Med. – 2013. – Vol. 27. – P. 648-653. http://dx.doi.org/10.1007/s12149-013-0730-8

Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT / D.H. Szolar, M. Korobkin, P. Reittner [et al.] // Radiology. – 2005. – Vol. 234. – P. 479-485. http://dx.doi.org/10.1148/radiol.2342031876

Analysis of adrenal masses by I8F-FDG positron emission tomography scanning / S.J. Han, T.S. Kim, S.W. Jeon [et al.] // Int. J. Clin. Pract. – 2007. – Vol. 61. – P. 802-809. http://dx.doi.org/10.1111/j.1742-1241.2006.01220.x

Blake M.A. PET/CT for adrenal assessment / M.A Blake, P. Prakash, C.G. Cronin // AJR. – 2010. – Vol. 195. – P. W91-W95. http://dx.doi.org/10.2214/ajr.09.3845

Boellaard R. Standards for PET image acquisition and quantitative data analysis / R. Boellaard // J. Nucl. Med. – 2009. – Vol. 50. – P. 11S-20S. http://dx.doi.org/10.2967/jnumed.108.057182

Changing role of imaging-guided percutaneus biopsy of adrenal masses: evaluation of 50 adrenal biopsies / S.D. Paulsen, H.V. Nghiem, M. Korobkin [et al.] // AJR. – 2004. – Vol. 182. – P. 1033-1037. http://dx.doi.org/10.2214/ajr.182.4.1821033

Characterization of adrenal masses by using FDG PET: a systematic review and meta-analysis of diagnostic test performance / G.W. Boland, B.A. Dwamena, M. Jagtiani Sangwaiya [et al.] // Radiology. – 2011. – Vol. 259. – P. 117-126. http://dx.doi.org/10.1148/radiol.11100569

Characterization of the normal adrenal gland with 18 F-FDG PET/CT / B. Bagheri, A.H. Maurer, L. Cone [et al.] // J. Nucl. Med. – 2004. – Vol. 45. – P. 1340-1343.

Chong S. Integrated PET/CT for the characterization of adrenal glands lesions in cancer patients: diagnostic efficacy and interpretation pitfalls / S. Chong, K.S. Lee, A.H. Kim // RadioGraphics. – 2006. – Vol. 26. – P. 1811-1826. http://dx.doi.org/10.1148/rg.266065057

Clinical utility of PET-FDG imaging in differentiation benign from malignant adrenal masses in lung cancer / N.C.Gupta, GM. Graeber, W.J. Tamim [et al.] // Clin. Lung Cancer. – 2001. – Vol. 3. – P. 59-64. http://dx.doi.org/10.3816/clc.2001.n.019

nC-metomidate PET imaging of adrenocortical cancer / T.S. Khan, A. Sundin, С Juhlin [et al.] // Eur. J. Nucl. Med. – 2003. – Vol. 30. – P. 403-410. http://dx.doi.org/10.1007/s00259-002-1025-9

[nC]Metomidate positron emission tomography of adrenocortical tumors in correlation with histopathological findings / J. Hennings, O. Lindhe, B. Bergstrom [et al.] // J. Clin. Endocrinol. Methab. – 2006. – Vol. 91. – P. 1410-1414. http://dx.doi.org/10.1210/jc.2005-2273

Collision adrenal tumors on PET/CT / MA. Blake, A. T. Sweeney, M.K. Kalra [et al.] // AJR. – 2004. – Vol. 183. – P. 864-865. http://dx.doi.org/10.2214/ajr.183.3.1830864

Comparison of delayed enhanced CT and 18F-FDG PET/ CT in the evaluation of adrenal masses in oncology patients / B.K. Park, C.K. Kim, B. Kim [et al.] // J. Comput. Assist. Tomogr. – 2007. – Vol. 31. – P. 550-556. http://dx.doi.org/10.1097/rct.0b013e31802fa8e1

Comparison of 6-[18F]-fluorodopamine positron emission tomography to [123I]-metaiodobenzylguanidine and [mIn]-pentetreotide scintigraphy in the localization of non-metastatic and metastatic pheochromocytoma /1. Ilias, C.C. Chen, J.A. Carrasquillo [et al.] // J. Nucl. Med. – 2008. – Vol. 49. – P. 1613-1619. http://dx.doi.org/10.2967/jnumed.108.052373

Contemporary adrenal scintigraphy / M.D. Gross, A. Avram, L.M. Fig, D. Rubello // Eur. J. Nucl. Med. Mol. Imaging. – 2007. – Vol. 34. – P. 547-557. http://dx.doi.org/10.1007/s00259-006-0265-5

Current trends in functional imaging of pheochromocytomas and paragangliomas / B.L. Shulkin, I. Ilias, J.C. Sisson, K. Pacak // Ann. N. Y. Acad. Sci. – 2006. – Vol. 1073. – P. 374-382. http://dx.doi.org/10.1196/annals.1353.041

Delayed enhanced CT for differentiation of benign from malignant adrenal masses / M. Korobkin, F.J. Brodeur, J.R Francis [et al] // Radiology. – 1996. – Vol. 200. – P. 737-742. http://dx.doi.org/10.1148/radiology.200.3.8756924

Diagnostic and prognostic value of 18-fluorodeoxyglucose positron emission tomography in adrenocortical carcinoma: a prospective comparison with computed tomography / S. Leboulleux, С Dromain, G. Bonniaud [et al.] // J. Clin. Endocrinol. Methab. – 2006. – Vol. 91. – P. 920-925. http://dx.doi.org/10.1210/jc.2005-1540

Differentiating adrenal adenomas from nonadenomas using 18-F-FDG PET/CT: quantitative and qualitative evaluation / E.M. Caoili, M. Korobkin, R.K.J. Brown [et al.] // Akad. Radiol. – 2007. – Vol. 14. – P. 468-475. http://dx.doi.org/10.1016/j.acra.2007.01.009

Differentiation of adrenal adenomas (lipid rich and lipid poor) from nonadenomas by use of washout characteristics on delayed enhanced CT / M. Kebapci, T. Kaya, E. Gurbuz [et al] // Abdom. Imaging. – 2003. – Vol. – 28. – P. 709-715. http://dx.doi.org/10.1007/s00261-003-0015-0

Differentiation of adrenal adenomas from nonadenomas using CT attenuation values / M. Korobkin, F.J. Brodeur, GG. Yutzy [et al.] // Am. J. Roentgenol. – 1996. – Vol. 16. – P. 531-536. http://dx.doi.org/10.2214/ajr.166.3.8623622

Discordant localization of 2-[18F]-fluoro-2-deoxy-D-glucose in 6-[18F]-fluorodopamine- and [(123)I]-metaiodobenzylguanidine-negative metastatic pheochromocytoma sites / M. Mamede, J.A. Carrasquillo, C.C. Chen [et al.] //Nucl. Med. Commun. – 2006. – Vol. 27. – P. 31-36. http://dx.doi.org/10.1097/01.mnm.0000189780.54658.e8

FDG PET in adrenocortical carcinoma / A. Becherer, H. Vierhapper, С Potzi [et al.] // Cancer Biother. Radiopharm. – 2001. – Vol. 16. – P. 289-295. http://dx.doi.org/10.1089/108497801753131363

FDG PET and CT characterization of adrenal lesions in cancer patients / S. Jana, T. Zhang, D.M. Milstein [et al.] // Eur. J. Nucl. Med. Mol. Imaging. – 2006. – Vol. 33. – P. 29-35. http://dx.doi.org/10.1007/s00259-005-1915-8

F-FDG PET/CT in the evaluation of adrenal masses / U. Metser, E. Miller, H. Lerman [et al.] // J. Nucl. Med. – 2006. – Vol. 47. – P. 32-37.

F-FDG PET in evaluation of adrenal lesions in patients with lung cancer / R. Kumar, Y. Xiu, J.Q. Yu [et al.] // J. Nucl. Med. – 2004. – Vol. 45. – P. 2058-2062.

F-FDG-PET/CT in the characterization surgical decision concerning adrenal masses: a prospective multicentre evaluation / С Ansquer, S. Scigliano, E. Mirallie [et al] // Eur. J. Nucl. Med. Mol. Imaging. – 2010. – Vol. 37. – P. 1669-1678. http://dx.doi.org/10.1007/s00259-010-1471-8

(18)F-FDG PET versus (18)F-FDG PET/CT for adrenal gland lesion characterization: a comparison of diagnostic efficacy in lung cancer patients / Y.M. Sung, K.S. Lee, B.T. Kim [et al.] // Korean J. Radiol. – 2008. – Vol. 9. – P. 19-28. http://dx.doi.org/10.3348/kjr.2008.9.1.19

F-DOPA PET is superior to conventional imaging with 123I-metaiodobenzylguanidine scintigraphy, CT, and MRI in localizing tumors causing cathecholamine excess / H.B. Feibrich, AH. Brouwers, M.N. Kerstens [et al.] // J. Clin. Endocrinol. Methab. – 2009. – Vol. 94. – P. 3922-3930. http://dx.doi.org/10.1210/jc.2009-1054

Gross M.D. Something old, something new, PET in adrenal imaging / M.D. Gross, D. Rubello // Eur. J. Nucl. Med. Mol. Imaging. – 2008. – Vol. 35. – P. 1233-1235. http://dx.doi.org/10.1007/s00259-008-0717-1

High diagnostic accuracy of adrenal core biopsy: results of the German and Austrian adrenal network multicenter trial in 220 consecutive patients / W. Saeger, M. Fassnacht, R. Chita [et al.] // Hum. Pathol. – 2003. – Vol. 34. – P. 180-186. http://dx.doi.org/10.1053/hupa.2003.24

High risk of malignancy in patients with incidentally discovered adrenal masses: accuracy of adrenal imaging and image-guided fine-needle aspiration cytology / F. Lumachi, S. Borsato, A. Tregnaghi [et al.] // Tumori. – 2007. – Vol. 93, N 3. – P. 269-274.

Ilias I. Diagnosis and management of tumors of the adrenal medulla / I. Ilias, K. Pacak // Horm. Metab. Res. – 2005. – Vol. 37. – P. 717-721. http://dx.doi.org/10.1055/s-2005-921091

Improved detection and characterization of adrenal disease with PET/CT / A.B. Elaini, S.K. Shetty, V.M. Chapman [et al] // RadioGraphics. – 2007. – Vol. 27. – P. 755-767. http://dx.doi.org/10.1148/rg.273055031

Incidental non-secreting adrenal masses in cancer patients: intraindividual comparison of F-fluorodeoxyglucose positron emission tomography/computed tomography with computed tomography and shift magnetic resonance imaging / S. Gratz, B. Klemke, W. Kaisr [et al.] // J. Int. Med. Res. – 2010. – Vol. 38. – P. 633-644. http://dx.doi.org/10.1177/147323001003800226

Incidental adrenal lesions: principles, techniques, and algorithms for imaging characterization / G.W. Boland, MA. Blake, P.F Hahn [et al] // Radiology. – 2008. – Vol. 249. – P. 756-775. http://dx.doi.org/10.1148/radiol.2493070976

Incidentally discovered adrenal masses / R.T. Kloos, M.D. Gross, I.R. Francis [et al] // Endocr. Rev. – 1995. – Vol. 16. – P. 460-484. http://dx.doi.org/10.1210/er.16.4.460

Integrated PET-CT for the characterization of adrenal gland lesions in cancer patients: efficacy and interpretation pitfalls / S. Chong, K.S. Lee, H.Y. Kim [et al.] // RadioGraphics. – 2006. – Vol. 26. – P. 1811-1824. http://dx.doi.org/10.1148/rg.266065057

Is computed tomography guided biopsy still necessary for the diagnosis of adrenal masses in patients with resectable non-small-cell lung cancer? / H.L. Porte, O.J. Ernst, T. Delebecq [et al.] // Eur. J. Cardiothorac. Surg. – 1999. – Vol. 15. – P. 597-601. http://dx.doi.org/10.1016/s1010-7940(99)00047-0

Management of patients with adrenal cancer: recommendations of an international consensus conference / D.E. Schteigart, G.M. Doherty, P.G Gauger [et al.] // Endocr. Relat. Cancer. – 2005. – Vol. 12. – P. 585-598. http://dx.doi.org/10.1677/erc.1.01029

Management of the clinically inapparent adrenal mass ("Incidentaloma") / MM. Grumbach, B.M.K. Biller, GD. Braunstein [et al.] // Ann. Intern. Med. – 2003. – Vol. 138. – P. 424-129. http://dx.doi.org/10.7326/0003-4819-138-5-200303040-00013

Mantero F. A comprehensive approach to adrenal incidentalomas / F. Mantero, N. Albiger // Arq. Bras. Endocrinol. Metab. – 2004. – Vol. 48, N 5. – P. 583-591. http://dx.doi.org/10.1590/s0004-27302004000500003

Metomidate-based imaging of adrenal masses / S. Hahner, A. Sundin // Horm. Cancer. – 2011. – Vol. 2. – P. 348-353. http://dx.doi.org/10.1007/s12672-011-0093-3

On behalf of the Study Group on Adrenal Tumors of the Italian Society of Endocrinology / F. Mantero, M. Terzolo, G Arnaldi [et al. ] // J. Clin. Endocrinol. Metab. – 2000. – Vol. 85. – P. 637-644. http://dx.doi.org/10.1210/jcem.85.2.6372

Percutaneous adrenal biopsy: review of a 10-year experience / T.J. Welch, P.F. Sheedy 2nd, D.H. Stephens [et al.] // Radiology. – 1994. – Vol. 193. – P. 341-344. http://dx.doi.org/10.1148/radiology.193.2.7972740

PET/CT for the characterization of adrenal masses in patients with cancer: qualitative versus quantitative accuracy in 150 consecutive patients / G.W. Boland, MA. Blake, N.S. Holalkere [et al] // AJR. – 2009. – Vol. 192. – P. 956-962. http://dx.doi.org/10.2214/ajr.08.1431

Pheochromocytomas: imaging with 2-[fluorine-18] fluoro-2-deoxy-D-glucose PET / B.L. Shulkin, N.W. Thompson, B. Shapiro [et al.] // Radiology. – 1999. – Vol. 212. – P. 35-41. http://dx.doi.org/10.1148/radiology.212.1.r99jl3035

Positron emission tomography imaging of adrenal masses: (18)F-fluorodeoxyglucose and the llbeta-hydroxylase tracer (ll)C-metomidate / G. Zettinig, M. Mitterhauser, W. Wadsak [et al.] // Eur. J. Nucl. Med. Mol. Imaging. – 2004. – Vol. 31. – P. 1224-1230. http://dx.doi.org/10.1007/s00259-004-1575-0

Prevalence of adrenal incidentaloma in a contemporary computerized tomography series / S. Bovio, A. Cataldi, G. Reimondo [et al.] / J. Endocrinol. Invest. – 2006. – Vol. 29. – P. 298-302. http://dx.doi.org/10.1007/bf03344099

Primary adrenocortical carcinoma: CT evaluation with clinical correlation / E.K. Fishman, B.M. Deutch, D.S. Hartman [et al.] // Am. J. Roentgenol. – 1987. – Vol. 148. – P. 531-535. http://dx.doi.org/10.2214/ajr.148.3.531

Role of ultrasonography in the detection of small adrenal masses / J. Trojan, W. Schwarz, С Sarrazin [et al.] // Ultaschall. Med. – 2002. – Vol. 23, N 2. – P. 96-100. http://dx.doi.org/10.1055/s-2002-25190

Song J.H. The incidental adrenal mass on CT: prevalence of adrenal disease in 1049 consecutive adrenai masses in patients with no known malignancy / J.H. Song, F.S. Chaudhry, W.W. Mayo-Smith. // AJR. – 2008. – Vol. 190. – P. 1163-1168. http://dx.doi.org/10.2214/ajr.07.2799

Szolar D.H. Adrenal adenomas and non adenomas: assessment of washout at delayed contrast-enhanced CT / D.H. Szolar, F. Kammerhuber // Radiology. – 1998. – Vol. 207. – P. 369-375. http://dx.doi.org/10.1148/radiology.207.2.9577483

Szolar D.H. Quantitative CT evaluation of adrenal gland masses: a step forward in the differentiation between adenomas and nonadenomas? / D.H. Szolar, F. Kammerhuber // Radiology. – 1997. – Vol. 202. – P. 517-521. http://dx.doi.org/10.1148/radiology.202.2.9015083

The clinically inapparent adrenal mass: update in diagnosis and treatment / G. Mansmann, J. Lau, E. Blak [et al.] // Endocr. Rev. – 2004. – Vol. 25. – P. 309-340. http://dx.doi.org/10.1210/er.2002-0031

The diagnostic role of radionuclide imaging in evaluation of patients with nonhypersecreting adrenal masses / S. Maurea, M. Klain, С Mainolfi [et al] // J. Nucl. Med. – 2000. – Vol. 42. – P. 884-892.

The optimal imaging of adrenal tumours: a comparison of different methods /1. Ilias, A. Sahdev, RH. Reznek [et al.] // Endocr. Relat. Cancer. – 2007. – Vol. 14. – P. 587-599. http://dx.doi.org/10.1677/erc-07-0045

The prevalence of adrenal incidentaloma in routine clinical practice / С Davenport, A. Liew, B. Doherty [et al.] // Endocrine. – 2011. – Vol. 40. – P. 80-83. http://dx.doi.org/10.1007/s12020-011-9445-6

Usefulness of standardized uptake values for distinguishing adrenal glands with pheochromocytoma from normal adrenal glands by use of 6-18F-fluorodopamine PET / H.J. Timmers, J.A. Carrasquillo, M. Whatley [et al.] // J. Nucl. Med. – 2007. – Vol. 48. – P. 1940-1944. http://dx.doi.org/10.2967/jnumed.107.043281

Use of 6-[18F]-fluorodopamine positron emission tomography (PET) as first-line investigation for the diagnosis and localization of non-metastatic phaeochromocytoma (PHEO) / H.J. Timmers, G. Eisenhofer, J.A Carrasquillo [et al.] // Clin. Endocrinol. (Oxf.). – 2009. – Vol. 71. – P. 11-17. http://dx.doi.org/10.1111/j.1365-2265.2008.03496.x

Utilisation of combined 18F-FDG PET/CT scan for differential diagnosis between benign and malignant adrenal enlargement / J.Y. Kim, S.H. Kim, H.J. Lee [et al.] // Br. J. Radiol. – 2013. – Vol. 86. – 20130190. http://dx.doi.org/10.1259/bjr.20130190

Utility of PET/CT in differentiating benign from malignant adrenal nodules in patients with cancer / R. Vikram, H.D. Yeung, H.A. Macapinlac [et al] // Am. J. Roentgenol. – 2008. Vol. 191. – P. 1545-1551. http://dx.doi.org/10.2214/ajr.07.3447

What parameters from 18F-FDG PET/CT are useful in evaluation of adrenal lesions? / J. Kunikowska, R. Matyskiel, S. Toutounchi [et al.] // Eur. J. Nucl. Med. Mol. Imaging. – 2014. – Vol. 41. – P. 2273-2280. http://dx.doi.org/10.1007/s00259-014-2844-1

Young W.F. Jr. The incidentally discovered adrenal mass / W.F. Young Jr. // N. Engl. J. Med. – 2007. – Vol. 356. – P. 601-610. http://dx.doi.org/10.1056/nejmcp065470

Young W.F. Management approaches to adrenal incidentalomas: a view from Rochester, Minnesota / W.F. Young // Endocrinol. Metab. Clin. North. Am. – 2000. – Vol. 29. – P. 159-185. http://dx.doi.org/10.1016/s0889-8529(05)70122-5